// App-Quantinova.ai

202 : Performance of Khorana Score to Predict One-Year Risk of Venous Thromboembolism in over Two Million Patients with Cancer

Researchers

Presenter

  • Yasmin Arafah

Principal Investigators

  • Taha Al-Juhaishi

  • Ghaith Abu Zeinah

  • Lalitha V. Nayak

  • Sadeer Al-Kindi

Medical Centers

  • Department of Medicine, Case Western Reserve University and University Hospitals Cleveland Medical Center, Cleveland, OH

  • Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Richard T. Silver Myeloproliferative Neoplasms Center, NewYork-Presbyterian Weill Cornell Medical Center, New York, NY

  • Department of Medicine, Division of Hematology-Oncology, Case Western Reserve University/University Hospital Case Medical Center, Cleveland, OH

  • Division of Cardiology, Harrington Heart and Vascular Institute, Case Western Reserve University and University Hospitals, Cleveland, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved